Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (NYSE: HUM) is a U.S. healthcare company in the direct health and medical insurance carriers industry, with operations spanning insurance services and CenterWell health care services. News about Humana often centers on its Medicare Advantage and Medicaid activities, partnerships that expand care models, and initiatives that address social determinants of health and health equity.
Recent announcements highlight Humana’s focus on Medicare Advantage, including earnings guidance updates and investor communications disclosed through Form 8-K filings, as well as program-specific developments such as Humana USAA Honor Giveback plans that are designed with veterans’ needs in mind. These co-branded Medicare Advantage plans feature benefits like $0 copays for in-network primary care and in-network mental health services, Part B givebacks and coverage for dental, vision and hearing, while remaining available to any eligible Medicare beneficiary in the covered areas.
Humana news also reflects its emphasis on value-based care and integrated support for complex conditions. The company has announced a partnership with Atlas Oncology Partners to offer a coordinated oncology care model for eligible Humana Medicare Advantage members in Tennessee and Mississippi, bringing together interdisciplinary care teams, care coordination, psychosocial support and advanced supportive care. In parallel, CenterWell Senior Primary Care and Conviva Senior Primary Care have partnered with Thyme Care to provide continuous, oncology-focused support to eligible patients across several states.
Beyond insurance and clinical partnerships, Humana-related coverage includes updates from the Humana Foundation on research into loneliness among underserved boys and food insecurity among seniors, as well as community impact awards through Humana Healthy Horizons in Oklahoma to organizations addressing food, housing and employment needs. Visitors to this page can explore earnings-related updates, ratings actions from agencies such as AM Best, leadership transitions, philanthropic reports and community initiatives that illustrate how Humana combines insurance, care delivery and community investment.
CenterWell Pharmacy (NYSE:HUM) and Mark Cuban Cost Plus Drug Company are expanding a partnership to develop employer-focused prescription solutions. Cost Plus Drugs selected CenterWell as a pharmacy partner and CenterWell will adopt the SwiftyRx™ platform to support medication order intake and home delivery for eligible Humana associates.
The collaboration aims to streamline onboarding, automate benefit checks, reduce cost-to-fill, and improve operational efficiency to lower patient medication costs.
CenterWell (NYSE: HUM) introduced the CenterWell Fulfillment Index on April 20, 2026, a new national measure built from 72 indicators to track wellbeing in adults 62+. The Index found 54% of adults 62+ report feeling fulfilled and highlights dips around ages 65–69, aiming to guide whole-person care.
The Index is intended for routine use by care teams to identify nonmedical needs tied to purpose, connection, comfort, independence, and security.
Humana (NYSE: HUM) declared a quarterly cash dividend of $0.885 per share, payable on July 31, 2026 to stockholders of record at the close of business on June 26, 2026.
The board's action delivers a near-term cash distribution to shareholders and reiterates the company's routine capital-return practice. Contact information for investor relations and corporate communications is provided.
Humana (NYSE:HUM) and University of Chicago Medicine report a phone-based, pharmacist-led inhaler education program that improved technique among Medicare Advantage beneficiaries with COPD.
Of ~1,900 participants, inhaler misuse fell from nearly 40% at baseline to under 7% after the first phone session; multi-session follow-up helped sustain correct use across device types and subgroups.
Tuesday Health and Humana (NYSE: HUM) announced a partnership launching June 1, 2026 to expand value-based palliative care for eligible Humana members in Texas. The program offers interdisciplinary teams, in-person and virtual visits, 24/7 clinical access, symptom management and caregiver support.
According to the companies, the service is designed to improve quality of life, align care with patient goals, and extend Tuesday Health's national footprint.
Humana (NYSE: HUM) elected Robert S. Field to its Board of Directors effective immediately following the Company’s 2026 Annual Meeting of Stockholders on April 10, 2026. Field is Principal and Managing Member of ηMed Capital Management and has two decades of healthcare investing experience.
Humana said Field’s expertise in investment evaluation, risk oversight, capital allocation, and legal/regulatory dynamics will support the company’s strategy and Board refreshment, following shareholder engagement that included input from Sessa Capital.
Humana (NYSE:HUM) has gone live with b.well Connected Health to centralize member health data and support interoperability commitments on April 9, 2026. Humana will leverage b.well’s national network to access normalized longitudinal records across providers, plans, labs, wearables and digital apps in real time.
This collaboration supports Humana’s CMS Health Technology Ecosystem pledge, aims to reduce administrative waste, enable point-of-claims data access, and participates in an HHS interoperability demonstration.
Humana (NYSE:HUM) and CPESN® USA launched a Pharmacist Quality Rewards program in Ohio on April 8, 2026 to improve care for members with hypertension and diabetes. The value-based program financially rewards community pharmacists for closing care gaps tied to NCQA HEDIS measures including CBP, GSD (A1c <8%), and BPD.
Participating CPESN pharmacies receive member lists and point-of-care tools to identify gaps, offer same-day testing, notify prescribers of out-of-range results, and encourage follow-up care.
Humana (NYSE: HUM) released its corrected 2025 Impact Report on April 6, 2026, detailing progress on simpler, more affordable, and connected care.
Key metrics: nearly 8 million Medicare Advantage/PDP members supported, 1.48 million Medicaid members served, 24.3% fewer inpatient admissions in value‑based care, and a 38% vehicle fleet footprint reduction.
Humana (NYSE:HUM) released its 2025 Impact Report outlining progress on affordability, access, community programs and environmental stewardship. Key metrics include support for nearly 8 million Medicare Advantage and prescription drug plan members, 1.48 million Medicaid members, 24.3% fewer inpatient admissions and a 38% vehicle fleet footprint reduction.
The report highlights community outreach (1.6 million lives via Humana Community Day), workforce belonging at 78%, and a 93% waste diversion rate across sites.